Prometheus Biosciences, Inc., was incorporated in Delaware on October 26, 2016. This is a biotechnology company that pioneered a precision medicine approach to discover, develop and commercialize novel therapeutic and companion diagnostic products. They leverage their proprietary precision medicine platform to identify new therapeutic targets and develop candidate therapeutic agents to participate in these targets. At the same time, they are developing companion diagnostic tests designed to identify patients who are more likely to respond to therapeutic drug candidates. 

RXDX(Delisted)

RXDX Profile